AIA Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $204K | Buy |
3,720
+595
| +19% | +$32.7K | ﹤0.01% | 326 |
|
|
2025
Q1 | $221K | Sell |
3,125
-580
| -16% | -$41K | 0.01% | 309 |
|
|
2024
Q4 | $244K | Buy |
3,705
+270
| +8% | +$17.7K | 0.01% | 280 |
|
|
2024
Q3 | $241K | Buy |
3,435
+458
| +15% | +$32.2K | 0.01% | 281 |
|
|
2024
Q2 | $245K | Sell |
2,977
-1,099
| -27% | -$90.5K | 0.01% | 274 |
|
|
2024
Q1 | $356K | Buy |
4,076
+266
| +7% | +$23.2K | 0.01% | 259 |
|
|
2023
Q4 | $367K | Sell |
3,810
-563
| -13% | -$54.3K | 0.02% | 250 |
|
|
2023
Q3 | $387K | Sell |
4,373
-370
| -8% | -$32.7K | 0.02% | 235 |
|
|
2023
Q2 | $411K | Sell |
4,743
-4,767
| -50% | -$413K | 0.02% | 265 |
|
|
2023
Q1 | $925K | Buy |
9,510
+5,197
| +120% | +$505K | 0.05% | 162 |
|
|
2022
Q4 | $446K | Buy |
4,313
+2,707
| +169% | +$280K | 0.03% | 237 |
|
|
2022
Q3 | $136K | Sell |
1,606
-1,106
| -41% | -$93.7K | 0.01% | 340 |
|
|
2022
Q2 | $225K | Buy |
+2,712
| New | +$225K | 0.01% | 344 |
|